Xencor (XNCR) EPS (Weighted Average and Diluted) Growth (1y) (2014 - 2026)
Xencor (XNCR) EPS (Weighted Average and Diluted) Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-79.34% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Xencor |
953.38 Mn |
878.64 Mn |
- |
-159.09% |
| Date | Value |
|---|
| Mar 31, 2026 |
-159.09% |
| Dec 31, 2025 |
84.48% |
| Sep 30, 2025 |
88.89% |
| Jun 30, 2025 |
62.39% |
| Mar 31, 2025 |
45.00% |
| Dec 31, 2024 |
-34.88% |
| Sep 30, 2024 |
-80.00% |
| Jun 30, 2024 |
-194.59% |
| Mar 31, 2024 |
-17.65% |
| Dec 31, 2023 |
-104.76% |
| Sep 30, 2023 |
27.27% |
| Jun 30, 2023 |
35.09% |
| Mar 31, 2023 |
-361.54% |
| Dec 31, 2022 |
-117.36% |
| Sep 30, 2022 |
20.29% |
| Jun 30, 2022 |
-165.52% |
| Mar 31, 2022 |
1,075.00% |
| Dec 31, 2021 |
604.17% |
| Sep 30, 2021 |
-213.64% |
| Jun 30, 2021 |
242.62% |
